Scientific Program

Conference Series LLC Ltd invites all the participants across the globe to attend International conference on Dual Diagnosis and Disorders Melbourne, Australia.

Day 1 :

Keynote Forum

Scott Stevens

Fouder-Health Tap, USA

Keynote: Look what dragged the cat in: The rise of the opioid crisis

Time : 10:00-11:00

Dual Diagnosis Disorders 2018 International Conference Keynote Speaker Scott Stevens photo
Biography:

Stevens is a journalist, posting regularly on health and alcohol issues for online news services and is a founding influencer at the world's largest medical portal, HealthTap. Stevens blends intensive evidence-based research, wit, journalistic objectivity, blunt personal dialogue and no-nonsense business perspective in his four award-winning health and addiction books.

Abstract:

The decade of the 2010's shelled hospitals and first responders with an explosion of opioid-related illness, injury, and death. Preventable drug overdoses tallied 54,793 lives lost in 2016 – an increase of 391 percent since 1999. Accidental drug overdose deaths increased 327 percent over the same period. The majority of OD deaths (38,000) involve opioids, The drug category most frequently involved in opioid overdoses and growing at the fastest pace includes fentanyl, fentanyl analogs, and tramadol. The fentanyl category of opioids accounted for nearly half of opioid-related deaths. The dirty cat in the litter, heroin, accounted for the second highest number of deaths, claiming 14,606 lives.

Western countries struggle with what the opioid cat dragged in: Hard-to-treat opioid addictions, fatal relapses, and needless loss of mainly young lives. Now legislators, first responders, treatment pros, and those in the medical field are forced to focus not on the death toll the cat dragged in, but instead what dragged the cat in.

 

Dual Diagnosis Disorders 2018 International Conference Keynote Speaker Jerome Ndolesha photo
Biography:

Jerome Ndolesha is a MSc Dual Diagnosis Specialist graduate from the Institute of Psychiatry at the Maudsley and Middlesex University, London, with a wealth of international experience. As a well-travelled missionary, he set up a literacy charity for inmates in Nioro du Sahel Prison (Mali, West Africa), an experience very crucial to executing his role as the President of the International Missionary Institute of London (2002-2003). Having established the current Zambian Catholic Community in London (1999–2002), he subsequently line-managed a community care service in both North and North West London. Further, he spearheaded Big-Lottery Funded Dual Diagnosis projects in the East London Boroughs of Hackney and Tower Hamlets. Possessing various degrees and Post-Graduate diplomae from Kahangala (Tanzania), Middlesex University (UK) Louvain University (Belgium) and Kingston and St Georges Universities (UK), he is currently enrolled on an MA in Law at the University of Law (London Bloomsbury) and pursuing his PHD in African Politics. He has a great passion renewable energy, mining and general construction. English aside, his fluent languages include French, Swahili, Bambara, Bemba and Lungu/Mambwe. Jerome is hugely privileged to be part of this conference as one of our guest speaker.

 

Abstract:

Confusingly, ‘Dual Diagnosis’ describes innumerable physical, psychological/developmental co-morbidity. However, the National Institute for Health and Clinical Excellence (NICE, 2016) defines the phenomenon as the coexistence of severe mental illness and licit/illicit psychoactive substance misuse, embracing patients who meet the criteria of the Diagnostic and Statistical Manual of Mental Disorders, Forth Edition (2000) (DSM-IV), and the International Statistical Classification of Diseases and Related Health Problems, 10th Revision (2016) (ICD-10). Nevertheless, since Dual Diagnosis is NOT a diagnosis in itself, inconsistent drug/alcohol misuse operational definitions and diagnostic classifications exist within the DSM-IV (and DSM-V) and the ICD-10. Such uncertainties contribute to making Dual Diagnosis a significant global clinical problem, often closely associated with increased risk of socio-economic exclusion, serious physical illness, self-harm, frequent re-hospitalization, poor treatment outcomes suicide/premature death, staff difficulties and management problems.